Rifaximin vs conventional oral therapy for hepatic encephalopathy: A meta-analysis

Figure 1 Flowchart of the included studies.

Figure 2 Efficacy of rifaximin vs oral disaccharides, rifaximin vs other oral antibiotics and rifaximin vs control therapy which included the combination of oral disaccharides and other antibiotics. M-H: Mantel Haenszel.

Figure 3 Adverse events experienced by patients treated with rifaximin vs control therapy. M-H: Mantel Haenszel.

Figure 4 Serum ammonia levels at the end of the treatment protocols: rifaximin vs oral disaccharides, rifaximin vs other oral antibiotics and rifaximin vs control therapy which included the combination of oral disaccharides and other antibiotics. IV: Inverse variance.